目次

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market by Geography
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Market Segmentation by Drug Class
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis

3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global Anti-Obesity Drugs Market 2018 - 2022
Historic Market Size - Data Table on Global Anti-Obesity Drugs Market 2018 - 2022 ($ million)
4.2 Type segment analysis 2018 - 2022
Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.3 Drug Class segment analysis 2018 - 2022
Historic Market Size - Drug Class Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type
6.1 Market segments
Chart on Type - Market share 2023-2028 (%)
Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
6.3 Class III anti-obesity drugs - Market size and forecast 2023-2028
Chart on Class III anti-obesity drugs - Market size and forecast 2023-2028 ($ million)
Data Table on Class III anti-obesity drugs - Market size and forecast 2023-2028 ($ million)
Chart on Class III anti-obesity drugs - Year-over-year growth 2023-2028 (%)
Data Table on Class III anti-obesity drugs - Year-over-year growth 2023-2028 (%)
6.4 Class II anti-obesity drugs - Market size and forecast 2023-2028
Chart on Class II anti-obesity drugs - Market size and forecast 2023-2028 ($ million)
Data Table on Class II anti-obesity drugs - Market size and forecast 2023-2028 ($ million)
Chart on Class II anti-obesity drugs - Year-over-year growth 2023-2028 (%)
Data Table on Class II anti-obesity drugs - Year-over-year growth 2023-2028 (%)
6.5 Class I anti-obesity drugs - Market size and forecast 2023-2028
Chart on Class I anti-obesity drugs - Market size and forecast 2023-2028 ($ million)
Data Table on Class I anti-obesity drugs - Market size and forecast 2023-2028 ($ million)
Chart on Class I anti-obesity drugs - Year-over-year growth 2023-2028 (%)
Data Table on Class I anti-obesity drugs - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by Drug Class
7.1 Market segments
Chart on Drug Class - Market share 2023-2028 (%)
Data Table on Drug Class - Market share 2023-2028 (%)
7.2 Comparison by Drug Class
Chart on Comparison by Drug Class
Data Table on Comparison by Drug Class
7.3 Peripherally acting drugs - Market size and forecast 2023-2028
Chart on Peripherally acting drugs - Market size and forecast 2023-2028 ($ million)
Data Table on Peripherally acting drugs - Market size and forecast 2023-2028 ($ million)
Chart on Peripherally acting drugs - Year-over-year growth 2023-2028 (%)
Data Table on Peripherally acting drugs - Year-over-year growth 2023-2028 (%)
7.4 Centrally acting drugs - Market size and forecast 2023-2028
Chart on Centrally acting drugs - Market size and forecast 2023-2028 ($ million)
Data Table on Centrally acting drugs - Market size and forecast 2023-2028 ($ million)
Chart on Centrally acting drugs - Year-over-year growth 2023-2028 (%)
Data Table on Centrally acting drugs - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Drug Class
Market opportunity by Drug Class ($ million)
Data Table on Market opportunity by Drug Class ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape2023-2028 (%)
Data Table on Market share By Geographical Landscape2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
Market opportunity By Geographical Landscape($ million)
Data Tables on Market opportunity By Geographical Landscape($ million)

10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business

12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 Alvogen Iceland ehf
Alvogen Iceland ehf - Overview
Alvogen Iceland ehf - Product / Service
Alvogen Iceland ehf - Key offerings
12.4 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product / Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
12.5 Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH - Overview
Boehringer Ingelheim International GmbH - Product / Service
Boehringer Ingelheim International GmbH - Key news
Boehringer Ingelheim International GmbH - Key offerings
12.6 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key news
Eli Lilly and Co. - Key offerings
12.7 Empros Pharma AB
Empros Pharma AB - Overview
Empros Pharma AB - Product / Service
Empros Pharma AB - Key offerings
12.8 ERX Pharmaceuticals Inc.
ERX Pharmaceuticals Inc. - Overview
ERX Pharmaceuticals Inc. - Product / Service
ERX Pharmaceuticals Inc. - Key offerings
12.9 Gelesis Inc.
Gelesis Inc. - Overview
Gelesis Inc. - Product / Service
Gelesis Inc. - Key offerings
12.10 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
12.11 Innovent Biologics Inc.
Innovent Biologics Inc. - Overview
Innovent Biologics Inc. - Product / Service
Innovent Biologics Inc. - Key offerings
12.12 LG Chem Ltd.
LG Chem Ltd. - Overview
LG Chem Ltd. - Business segments
LG Chem Ltd. - Key news
LG Chem Ltd. - Key offerings
LG Chem Ltd. - Segment focus
12.13 Novo Nordisk AS
Novo Nordisk AS - Overview
Novo Nordisk AS - Business segments
Novo Nordisk AS - Key news
Novo Nordisk AS - Key offerings
Novo Nordisk AS - Segment focus
12.14 Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc. - Overview
Rhythm Pharmaceuticals Inc. - Product / Service
Rhythm Pharmaceuticals Inc. - Key news
Rhythm Pharmaceuticals Inc. - Key offerings
12.15 SCOHIA PHARMA Inc.
SCOHIA PHARMA Inc. - Overview
SCOHIA PHARMA Inc. - Product / Service
SCOHIA PHARMA Inc. - Key news
SCOHIA PHARMA Inc. - Key offerings
12.16 VIVUS LLC
VIVUS LLC - Overview
VIVUS LLC - Product / Service
VIVUS LLC - Key offerings
12.17 Zydus Lifesciences Ltd.
Zydus Lifesciences Ltd. - Overview
Zydus Lifesciences Ltd. - Business segments
Zydus Lifesciences Ltd. - Key news
Zydus Lifesciences Ltd. - Key offerings
Zydus Lifesciences Ltd. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 market analysis
market analysis
13.10 List of abbreviations
List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Anti-Obesity Drugs Market 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Drug Class Segment 2018 - 2022 ($ million)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on Type - Market share 2023-2028 (%)
Exhibits33: Data Table on Type - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by Type
Exhibits35: Data Table on Comparison by Type
Exhibits36: Chart on Class III anti-obesity drugs - Market size and forecast 2023-2028 ($ million)
Exhibits37: Data Table on Class III anti-obesity drugs - Market size and forecast 2023-2028 ($ million)
Exhibits38: Chart on Class III anti-obesity drugs - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on Class III anti-obesity drugs - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on Class II anti-obesity drugs - Market size and forecast 2023-2028 ($ million)
Exhibits41: Data Table on Class II anti-obesity drugs - Market size and forecast 2023-2028 ($ million)
Exhibits42: Chart on Class II anti-obesity drugs - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Class II anti-obesity drugs - Year-over-year growth 2023-2028 (%)
Exhibits44: Chart on Class I anti-obesity drugs - Market size and forecast 2023-2028 ($ million)
Exhibits45: Data Table on Class I anti-obesity drugs - Market size and forecast 2023-2028 ($ million)
Exhibits46: Chart on Class I anti-obesity drugs - Year-over-year growth 2023-2028 (%)
Exhibits47: Data Table on Class I anti-obesity drugs - Year-over-year growth 2023-2028 (%)
Exhibits48: Market opportunity by Type ($ million)
Exhibits49: Data Table on Market opportunity by Type ($ million)
Exhibits50: Chart on Drug Class - Market share 2023-2028 (%)
Exhibits51: Data Table on Drug Class - Market share 2023-2028 (%)
Exhibits52: Chart on Comparison by Drug Class
Exhibits53: Data Table on Comparison by Drug Class
Exhibits54: Chart on Peripherally acting drugs - Market size and forecast 2023-2028 ($ million)
Exhibits55: Data Table on Peripherally acting drugs - Market size and forecast 2023-2028 ($ million)
Exhibits56: Chart on Peripherally acting drugs - Year-over-year growth 2023-2028 (%)
Exhibits57: Data Table on Peripherally acting drugs - Year-over-year growth 2023-2028 (%)
Exhibits58: Chart on Centrally acting drugs - Market size and forecast 2023-2028 ($ million)
Exhibits59: Data Table on Centrally acting drugs - Market size and forecast 2023-2028 ($ million)
Exhibits60: Chart on Centrally acting drugs - Year-over-year growth 2023-2028 (%)
Exhibits61: Data Table on Centrally acting drugs - Year-over-year growth 2023-2028 (%)
Exhibits62: Market opportunity by Drug Class ($ million)
Exhibits63: Data Table on Market opportunity by Drug Class ($ million)
Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits65: Chart on Market share By Geographical Landscape2023-2028 (%)
Exhibits66: Data Table on Market share By Geographical Landscape2023-2028 (%)
Exhibits67: Chart on Geographic comparison
Exhibits68: Data Table on Geographic comparison
Exhibits69: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits101: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits102: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits103: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits104: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits105: Market opportunity By Geographical Landscape($ million)
Exhibits106: Data Tables on Market opportunity By Geographical Landscape($ million)
Exhibits107: Impact of drivers and challenges in 2023 and 2028
Exhibits108: Overview on criticality of inputs and factors of differentiation
Exhibits109: Overview on factors of disruption
Exhibits110: Impact of key risks on business
Exhibits111: Companies covered
Exhibits112: Matrix on companies position and classification
Exhibits113: Alvogen Iceland ehf - Overview
Exhibits114: Alvogen Iceland ehf - Product / Service
Exhibits115: Alvogen Iceland ehf - Key offerings
Exhibits116: AstraZeneca Plc - Overview
Exhibits117: AstraZeneca Plc - Product / Service
Exhibits118: AstraZeneca Plc - Key news
Exhibits119: AstraZeneca Plc - Key offerings
Exhibits120: Boehringer Ingelheim International GmbH - Overview
Exhibits121: Boehringer Ingelheim International GmbH - Product / Service
Exhibits122: Boehringer Ingelheim International GmbH - Key news
Exhibits123: Boehringer Ingelheim International GmbH - Key offerings
Exhibits124: Eli Lilly and Co. - Overview
Exhibits125: Eli Lilly and Co. - Product / Service
Exhibits126: Eli Lilly and Co. - Key news
Exhibits127: Eli Lilly and Co. - Key offerings
Exhibits128: Empros Pharma AB - Overview
Exhibits129: Empros Pharma AB - Product / Service
Exhibits130: Empros Pharma AB - Key offerings
Exhibits131: ERX Pharmaceuticals Inc. - Overview
Exhibits132: ERX Pharmaceuticals Inc. - Product / Service
Exhibits133: ERX Pharmaceuticals Inc. - Key offerings
Exhibits134: Gelesis Inc. - Overview
Exhibits135: Gelesis Inc. - Product / Service
Exhibits136: Gelesis Inc. - Key offerings
Exhibits137: GlaxoSmithKline Plc - Overview
Exhibits138: GlaxoSmithKline Plc - Business segments
Exhibits139: GlaxoSmithKline Plc - Key news
Exhibits140: GlaxoSmithKline Plc - Key offerings
Exhibits141: GlaxoSmithKline Plc - Segment focus
Exhibits142: Innovent Biologics Inc. - Overview
Exhibits143: Innovent Biologics Inc. - Product / Service
Exhibits144: Innovent Biologics Inc. - Key offerings
Exhibits145: LG Chem Ltd. - Overview
Exhibits146: LG Chem Ltd. - Business segments
Exhibits147: LG Chem Ltd. - Key news
Exhibits148: LG Chem Ltd. - Key offerings
Exhibits149: LG Chem Ltd. - Segment focus
Exhibits150: Novo Nordisk AS - Overview
Exhibits151: Novo Nordisk AS - Business segments
Exhibits152: Novo Nordisk AS - Key news
Exhibits153: Novo Nordisk AS - Key offerings
Exhibits154: Novo Nordisk AS - Segment focus
Exhibits155: Rhythm Pharmaceuticals Inc. - Overview
Exhibits156: Rhythm Pharmaceuticals Inc. - Product / Service
Exhibits157: Rhythm Pharmaceuticals Inc. - Key news
Exhibits158: Rhythm Pharmaceuticals Inc. - Key offerings
Exhibits159: SCOHIA PHARMA Inc. - Overview
Exhibits160: SCOHIA PHARMA Inc. - Product / Service
Exhibits161: SCOHIA PHARMA Inc. - Key news
Exhibits162: SCOHIA PHARMA Inc. - Key offerings
Exhibits163: VIVUS LLC - Overview
Exhibits164: VIVUS LLC - Product / Service
Exhibits165: VIVUS LLC - Key offerings
Exhibits166: Zydus Lifesciences Ltd. - Overview
Exhibits167: Zydus Lifesciences Ltd. - Business segments
Exhibits168: Zydus Lifesciences Ltd. - Key news
Exhibits169: Zydus Lifesciences Ltd. - Key offerings
Exhibits170: Zydus Lifesciences Ltd. - Segment focus
Exhibits171: Inclusions checklist
Exhibits172: Exclusions checklist
Exhibits173: Currency conversion rates for US$
Exhibits174: Research methodology
Exhibits175: Information sources
Exhibits176: Data validation
Exhibits177: Validation techniques employed for market sizing
Exhibits178: Data synthesis
Exhibits179: 360 degree market analysis
Exhibits180: List of abbreviations